Michael Sharp, R.Ph. is currently President of SharpRx Pharmaceutical Consultation Services. In this capacity he has consulted with several clients, including Myers and Stauffer, the Centers for Medicare and Medicaid Services (CMS), multiple state Medicaid programs, several research and consulting bureaus, SVC Inc, the Indiana Hemophilia and Thrombosis Center, pharmaceutical manufacturers and the Indiana Attorney General’s Office Medicaid Fraud Control Unit. He also serves on the Board of Directors for 46brooklyn Research, an IRS-recognized 501(c)(3) Public Charity dedicated to pharmaceutical pricing transparency and utilization of public data for the common good.
Mike has played a significant and ongoing role in the CMS National Average Drug Acquisition Cost (NADAC) project. He has been heavily involved in the design, development, implementation, maintenance, management and stakeholder communications since the inception of the NADAC initiative in 2011. In addition, he has provided consultation on the Federal Medicaid Rebate program generic CPI penalty resulting in annual savings of greater than $450 million dollars.
Prior to his current position, Mike was the Director of Pharmacy for the State of Indiana Medicaid pharmacy program. In this capacity, he was responsible for all aspects of pharmacy benefit administration, including budgeting, staff supervision, legislative affairs, compliance with all state and federal laws and contractor performance related to drug rebates, clinical services, prior authorization, claims processing, reimbursement and implementation of new program initiatives. Mike represented Region V states on the CMS Pharmacy Technical Advisory Group.
Mike has significant experience in Medicaid pharmacy benefit management and has developed multiple innovative solutions for addressing program needs within the Medicaid pharmacy space. Areas of expertise include drug pricing, regulatory affairs, claims processing, pharmacy informatics, procedure coded drugs, drug rebates, expert testimony and both Medicaid and commercial pharmacy benefit management. Mike has pharmacy practice experience in the pharmaceutical industry (Eli Lilly and Company), drug file compendia (Medi-Span), long-term care and retail pharmacy. He has been a guest lecturer for pharmacy classes at both Butler and Purdue University. Mike holds a B.S. in Pharmacy Practice from Butler University College of Pharmacy and Health Sciences. He has been licensed as a pharmacist in the State of Indiana since 1993.
Learn more about the our Crossroads 2020 Speakers!
As a reporter who didn't start covering pharma until 2016, I really appreciated this great roundup of important drug approvals of last decade, from @adamfeuerstein n @matthewherper